{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Angelica sinensis", "Chinese herbal medicines", "breast cancer", "estrogenic herbs", "primary breast cancer cells", "safety"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31293425", "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "06", "Day": "25"}], "Language": ["eng"], "ELocationID": ["706", "10.3389/fphar.2019.00706"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2019"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Is Danggui Safe to be Taken by Breast Cancer Patients?-A Skepticism Finally Answered by Comprehensive Preclinical Evidence.", "Pagination": {"StartPage": "706", "MedlinePgn": "706"}, "Abstract": {"AbstractText": ["<i>Angelica sinensis</i> (AS, Danggui) has long been regarded to stimulate breast cancer growth; hence, the use of AS in breast cancer patients remains a major concern for both patients and practitioners. Since safety studies of herbs would be unethical to carry out in patients, the present study aimed to investigate the potential unsafe effects of AS in a systematic pre-clinical approach. Human breast cancer cells, breast orthotopic tumor-bearing mouse models, as well as primary breast cancer cells from patients' tumors were used to evaluate the effect of AS hot water extract on the progression of breast tumors and/or growth of breast cancer cells. We showed that AS is not that stimulatory in breast cancer both <i>in vitro</i> and <i>in vivo</i>, though AS should still be used with caution in estrogen receptor-positive breast cancer patients. This novel approach of applying breast cancer cell lines, xenograft, and syngeneic tumors models, as well as primary breast cancer cells from patients' tumors in Chinese medicines safety evaluation was proven feasible. Our finding is important information for patients, Chinese medicine practitioners, and clinicians on the safety use of AS in breast cancer, which will affect future clinical practice."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Yue", "ForeName": "Grace Gar-Lee", "Initials": "GG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Wong", "ForeName": "Lok-Sze", "Initials": "LS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Leung", "ForeName": "Hoi-Wing", "Initials": "HW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Gao", "ForeName": "Si", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Tsang", "ForeName": "Julia Yuen-Shan", "Initials": "JY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong."}], "LastName": "Lin", "ForeName": "Zhi-Xiu", "Initials": "ZX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Union Hospital, Shatin, Hong Kong."}], "LastName": "Law", "ForeName": "Bonita Ka-Bo", "Initials": "BK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Tse", "ForeName": "Gary Man-Kit", "Initials": "GM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Lau", "ForeName": "Clara Bik-San", "Initials": "CB"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Amato P., Christophe S., Mellon P. L. (2002). Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 9, 145\u2013150. 10.1097/00042192-200203000-00010", "ArticleIdList": ["10.1097/00042192-200203000-00010", "11875334"]}, {"Citation": "Boon H. S., Olatunde F., Zick S. M. (2007). Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 7, 4. 10.1186/1472-6874-7-4", "ArticleIdList": ["10.1186/1472-6874-7-4", "PMC1851951", "17397542"]}, {"Citation": "Chang C. J., Chiu J. H., Tseng L. M., Chang C. H., Chien T. M., Wu C. W., et al. (2006). Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells. Eur. J. Clin. Invest. 36, 588\u2013596. 10.1111/j.1365-2362.2006.01676.x", "ArticleIdList": ["10.1111/j.1365-2362.2006.01676.x", "16893382"]}, {"Citation": "Chien T. J., Lin C. P., Song Y. L., Hsu C. H. (2013). The impact of chemotherapy in cancer patients: reflection on traditional Chinese symptom complex, cancer-related fatigue, and quality of life. Holist. Nurs. Pract. 27, 273\u2013281. 10.1097/HNP.0b013e31829b93f4", "ArticleIdList": ["10.1097/HNP.0b013e31829b93f4", "23925347"]}, {"Citation": "Chinese Pharmacopoeia Commission (2015). Chinese Pharmacopoeia Vol. 1 (Beijing: China Medical Science Press; )."}, {"Citation": "Davis S. R., Lijovic M., Fradkin P., Bradbury J., La China M., Schwarz M., et al. (2010). Use of complementary and alternative therapy by women in the first 2\u00a0years after diagnosis and treatment of invasive breast cancer. Menopause 17, 1004\u20131009. 10.1097/gme.0b013e3181d991dd", "ArticleIdList": ["10.1097/gme.0b013e3181d991dd", "20505545"]}, {"Citation": "Dietz B. M., Hajirahimkhan A., Dunlap T. L., Bolton J. L. (2016). Botanicals and their bioactive phytochemicals for women\u2019s health. Pharmacol. Rev. 68, 1026\u20131073. 10.1124/pr.115.010843", "ArticleIdList": ["10.1124/pr.115.010843", "PMC5050441", "27677719"]}, {"Citation": "DiGianni L. M., Garber J. E., Winer E. P. (2002). Complementary and alternative medicine use among women with breast cancer. J. Clin. Oncol. 20, 34S\u201338S. 10.1200/JCO.2002.07.176", "ArticleIdList": ["10.1200/JCO.2002.07.176", "12235222"]}, {"Citation": "Fan L., Strasser-Weippl K., Li J. J., St Louis J., Finkelstein D. M., Yu K. D., et al. (2014). Breast cancer in China. Lancet Oncol. 15, e279\u2013e289. 10.1016/S1470-2045(13)70567-9", "ArticleIdList": ["10.1016/S1470-2045(13)70567-9", "24872111"]}, {"Citation": "\nFerlay J., Ervik M., Lam F., Colombet M., Mery L., Pi\u00f1eros M., et al. , (2018). Global Cancer Observatory: Cancer Today. https://gco.iarc.fr/today [Accessed on 28 Dec 2018]. "}, {"Citation": "Gao Q. T., Choi R. C., Cheung A. W., Zhu J. T., Li J., Chu G. K., et al. , (2007). Danggui buxue tang\u2013a Chinese herbal decoction activates the phosphorylations of extracellular signal-regulated kinase and estrogen receptor alpha in cultured MCF-7 cells. FEBS Lett. 581, 233\u2013240. 10.1016/j.febslet.2006.12.018", "ArticleIdList": ["10.1016/j.febslet.2006.12.018", "17187784"]}, {"Citation": "Gu X., Xu Z. Y., Zhu L. Y., Wang L. F., Li K., Pei Q. (2013). Dual control of Shuanghuang Shengbai granule on upstream and downstream signal modulators of CyclinD-CDK4/6 signaling pathway of cell cycle in Lewis-bearing mice with cyclophosphamide-induced myelosuppression. Onco Targets Ther. 6, 199\u2013209. 10.2147/OTT.S37407", "ArticleIdList": ["10.2147/OTT.S37407", "PMC3615883", "23569384"]}, {"Citation": "He H. L., Jin H., Wang J. F., Niu J. Z. (2002). [The research of estrogen receptor modulator and correlative Chinese herbs]. Zhongguo Zhong Yao Za Zhi 27, 805\u2013807.", "ArticleIdList": ["12776580"]}, {"Citation": "\nHong Kong Hospital Authority  (2018). Hong Kong Cancer Registry. In Cancer Facts. http://www3.ha.org.hk/cancereg/default.asp [Accessed on 28 Dec 2018]. "}, {"Citation": "Hollestelle A., Nagel J. H., Smid M., Lam S., Elstrodt F., Wasielewski M., et al. , (2010). Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res. Treat. 121, 53\u201364. 10.1007/s10549-009-0460-8", "ArticleIdList": ["10.1007/s10549-009-0460-8", "19593635"]}, {"Citation": "Holliday D. L., Speirs V. (2011). Choosing the right cell line for breast cancer research. Breast Cancer Res. 13, 215. 10.1186/bcr2889", "ArticleIdList": ["10.1186/bcr2889", "PMC3236329", "21884641"]}, {"Citation": "Hua Y., Yao W., Ji P., Wei Y. (2017). Integrated metabonomic-proteomic studies on blood enrichment effects of Angelica sinensis on a blood deficiency mice model. Pharm. Biol. 55, 853\u2013863. 10.1080/13880209.2017.1281969", "ArticleIdList": ["10.1080/13880209.2017.1281969", "PMC6130503", "28140733"]}, {"Citation": "Ji P., Wei Y., Hua Y., Zhang X., Yao W., Ma Q., et al. (2018). A novel approach using metabolomics coupled with hematological and biochemical parameters to explain the enriching-blood effect and mechanism of unprocessed Angelica sinensis and its 4 kinds of processed products. J. Ethnopharmacol. 211, 101\u2013116. 10.1016/j.jep.2017.09.028", "ArticleIdList": ["10.1016/j.jep.2017.09.028", "28958590"]}, {"Citation": "Killion J. J., Radinsky R., Fidler I. J. (1999). Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev. 17, 279\u2013284. 10.1023/A:1006140513233", "ArticleIdList": ["10.1023/A:1006140513233", "10352881"]}, {"Citation": "Kwon Y. (2014). Effect of soy isoflavones on the growth of human breast tumors: findings from preclinical studies. Food Sci. Nutr. 2, 613\u2013622. 10.1002/fsn3.142", "ArticleIdList": ["10.1002/fsn3.142", "PMC4256563", "25493176"]}, {"Citation": "Lai J. N., Wu C. T., Wang J. D. (2012). Prescription pattern of chinese herbal products for breast cancer in taiwan: a population-based study. Evid. Based Complement. Alternat. Med. 2012, 891893. 10.1155/2012/891893", "ArticleIdList": ["10.1155/2012/891893", "PMC3368194", "22685488"]}, {"Citation": "Lam Y. C., Cheng C. W., Peng H., Law C. K., Huang X., Bian Z. (2009). Cancer patients\u2019 attitudes towards chinese medicine: a Hong Kong survey. Chin. Med. 4, 25. 10.1186/1749-8546-4-25", "ArticleIdList": ["10.1186/1749-8546-4-25", "PMC2805668", "20042091"]}, {"Citation": "Lau C. B., Ho T. C., Chan T. W., Kim S. C. (2005). Use of dong quai (Angelica sinensis) to treat peri- or postmenopausal symptoms in women with breast cancer: is it appropriate? Menopause 12, 734\u2013740. 10.1097/01.gme.0000184419.65943.01", "ArticleIdList": ["10.1097/01.gme.0000184419.65943.01", "16278617"]}, {"Citation": "Lechner M. G., Karimi S. S., Barry-Holson K., Angell T. E., Murphy K. A., Church C. H., et al. (2013). Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy. J. Immunother. 36, 477\u2013489. 10.1097/01.cji.0000436722.46675.4a", "ArticleIdList": ["10.1097/01.cji.0000436722.46675.4a", "PMC3910494", "24145359"]}, {"Citation": "Lee Y., Jin Y., Lim W., Ji S., Choi S., Jang S., et al. (2003). A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J. Steroid Biochem. Mol. Biol. 84, 463\u2013468. 10.1016/S0960-0760(03)00067-0", "ArticleIdList": ["10.1016/S0960-0760(03)00067-0", "12732291"]}, {"Citation": "Li M., Yue G. G., Song L. H., Huang M. B., Lee J. K., Tsui S. K., et al. (2018). Natural small molecule bigelovin suppresses orthotopic colorectal tumor growth and inhibits colorectal cancer metastasis via IL6/STAT3 pathway. Biochem. Pharmacol. 150, 191\u2013201. 10.1016/j.bcp.2018.02.017", "ArticleIdList": ["10.1016/j.bcp.2018.02.017", "29454618"]}, {"Citation": "Li W., Guo J., Tang Y., Wang H., Huang M., Qian D., et al. (2012). Pharmacokinetic comparison of ferulic acid in normal and blood deficiency rats after oral administration of Angelica sinensis, Ligusticum chuanxiong and their combination. Int. J. Mol. Sci. 13, 3583\u20133597. 10.3390/ijms13033583", "ArticleIdList": ["10.3390/ijms13033583", "PMC3317729", "22489169"]}, {"Citation": "Li W., Tang Y., Guo J., Huang M., Qian D., Duan J. (2011). [Enriching blood effect comparison in three kinds of blood deficiency model after oral administration of drug pair of Angelicae Sinensis Radix and Chuanxiong Rhizoma and each single herb]. Zhongguo Zhong Yao Za Zhi 36, 1808\u20131814.", "ArticleIdList": ["22032150"]}, {"Citation": "Lin Y. H., Chiu J. H. (2011). Use of chinese medicine by women with breast cancer: a nationwide cross-sectional study in Taiwan. Complement. Ther. Med. 19, 137\u2013143. 10.1016/j.ctim.2011.04.001", "ArticleIdList": ["10.1016/j.ctim.2011.04.001", "21641518"]}, {"Citation": "Liu T. G., Xiong S. Q., Yan Y., Zhu H., Yi C. (2012). Use of chinese herb medicine in cancer patients: a survey in southwestern china. Evid. Based Complement. Alternat. Med. 2012, 769042. 10.1155/2012/769042", "ArticleIdList": ["10.1155/2012/769042", "PMC3446813", "22997534"]}, {"Citation": "Luo K. W., Yue G. G., Ko C. H., Lee J. K., Gao S., Li L. F., et al. (2014). In vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma. Phytomedicine 21, 1078\u20131087. 10.1016/j.phymed.2014.04.020", "ArticleIdList": ["10.1016/j.phymed.2014.04.020", "24856767"]}, {"Citation": "Ma H., Li L., Dou G., Wang C., Li J., He H., et al. (2017). Z-ligustilide restores tamoxifen sensitivity of ERa negative breast cancer cells by reversing MTA1/IFI16/HDACs complex mediated epigenetic repression of ERa. Oncotarget 8, 29328\u201329345. 10.18632/oncotarget.16440", "ArticleIdList": ["10.18632/oncotarget.16440", "PMC5438733", "28415616"]}, {"Citation": "McLay J. S., Stewart D., George J., Rore C., Heys S. D. (2012). Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur. J. Clin. Pharmacol. 68, 811\u2013819. 10.1007/s00228-011-1181-6", "ArticleIdList": ["10.1007/s00228-011-1181-6", "22166933"]}, {"Citation": "Piersen C. E. (2003). Phytoestrogens in botanical dietary supplements: implications for cancer. Integr. Cancer Ther. 2, 120\u2013138. 10.1177/1534735403002002004", "ArticleIdList": ["10.1177/1534735403002002004", "15035899"]}, {"Citation": "Qi H., Jiang Z., Wang C., Yang Y., Li L., He H., et al. (2017). Sensitization of tamoxifen-resistant breast cancer cells by Z-ligustilide through inhibiting autophagy and accumulating DNA damages. Oncotarget 8, 29300\u201329317. 10.18632/oncotarget.16832", "ArticleIdList": ["10.18632/oncotarget.16832", "PMC5438731", "28431397"]}, {"Citation": "Rice S., Whitehead S. A. (2006). Phytoestrogens and breast cancer\u2013promoters or protectors? Endocr. Relat. Cancer 13, 995\u20131015. 10.1677/erc.1.01159", "ArticleIdList": ["10.1677/erc.1.01159", "17158751"]}, {"Citation": "Roberts H. (2010). Safety of herbal medicinal products in women with breast cancer. Maturitas 66, 363\u2013369. 10.1016/j.maturitas.2010.02.010", "ArticleIdList": ["10.1016/j.maturitas.2010.02.010", "20347238"]}, {"Citation": "Smart C. E., Morrison B. J., Saunus J. M., Vargas A. C., Keith P., Reid L., et al. , (2013). In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity. PLoS One 8, e64388. 10.1371/annotation/1ba8c49a-f6cb-4565-8a36-7d7c429ea670", "ArticleIdList": ["10.1371/annotation/1ba8c49a-f6cb-4565-8a36-7d7c429ea670", "PMC3672101", "23750209"]}, {"Citation": "Tsang J. Y., Huang Y. H., Luo M. H., Ni Y. B., Chan S. K., Lui P. C., et al. (2012). Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer. Breast Cancer Res. Treat. 136, 407\u2013417. 10.1007/s10549-012-2271-6", "ArticleIdList": ["10.1007/s10549-012-2271-6", "23053657"]}, {"Citation": "Wong K. Y., Tan E. Y., Chen J. J., Teo C., Chan P. M. (2014). The use of traditional chinese medicine among breast cancer patients: implications for the clinician. Ann. Acad. Med. Singapore 43, 74\u201378.", "ArticleIdList": ["24652426"]}, {"Citation": "Wong L. Y., Leung P. C., Tang J. L., Mercer S. W. (2010). Use of dietary supplements by breast cancer patients undergoing conventional cancer treatment. Patient Prefer Adherence 4, 407\u2013414. 10.2147/PPA.S13639", "ArticleIdList": ["10.2147/PPA.S13639", "PMC3003607", "21206516"]}, {"Citation": "Xiao H., Xiong L., Song X., Jin P., Chen L., Chen X., et al. (2017). Angelica sinensis polysaccharides ameliorate stress-induced premature senescence of hematopoietic cell via protecting bone marrow stromal cells from oxidative injuries caused by 5-Fluorouracil. Int. J. Mol. Sci. 18 (11), E2265. 10.3390/ijms18112265", "ArticleIdList": ["10.3390/ijms18112265", "PMC5713235", "29143796"]}, {"Citation": "Yeh I. T., Mies C. (2008). Application of immunohistochemistry to breast lesions. Arch. Pathol. Lab. Med. 132, 349\u2013358.", "ArticleIdList": ["18318578"]}, {"Citation": "Yue G. G., Fung K. P., Tse G. M., Leung P. C., Lau C. B. (2006). Comparative studies of various ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro . J. Altern. Complement. Med. 12, 777\u2013789. 10.1089/acm.2006.12.777", "ArticleIdList": ["10.1089/acm.2006.12.777", "17034284"]}, {"Citation": "Yue G. G., Xie S., Lee J. K., Kwok H. F., Gao S., Nian Y., et al. (2016). New potential beneficial effects of actein, a triterpene glycoside isolated from Cimicifuga species, in breast cancer treatment. Sci. Rep. 6, 35263. 10.1038/srep35263", "ArticleIdList": ["10.1038/srep35263", "PMC5059658", "27731376"]}, {"Citation": "Zhang H., Wang H. F., Liu Y., Huang L. J., Wang Z. F., Li Y. (2014). The haematopoietic effect of Panax japonicus on blood deficiency model mice. J. Ethnopharmacol. 154, 818\u2013824. 10.1016/j.jep.2014.05.008", "ArticleIdList": ["10.1016/j.jep.2014.05.008", "24837302"]}, {"Citation": "Zhang M., Liu X., Li J., He L., Tripathy D. (2007). Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients. Cochrane Database Syst. Rev. (2), CD004921. 10.1002/14651858.CD004921.pub2", "ArticleIdList": ["10.1002/14651858.CD004921.pub2", "PMC9028047", "17443560"]}, {"Citation": "Zhou W. J., Wang S., Hu Z., Zhou Z. Y., Song C. J. (2015). Angelica sinensis polysaccharides promotes apoptosis in human breast cancer cells via CREB-regulated caspase-3 activation. Biochem. Biophys. Res. Commun. 467, 562\u2013569. 10.1016/j.bbrc.2015.09.145", "ArticleIdList": ["10.1016/j.bbrc.2015.09.145", "26431878"]}, {"Citation": "Zhu X. Y., Yang F. W., Li C. M., Li G. S., Liu Z. F. (2007). [Effects of the extracts of Angelica sinensis on the proliferation of PC3, HeLa, MDA-MB-435 cells]. Shandong J. Tradit. Chin. Med. 26, 776\u2013778. 10.3969/j.issn.0257-358X.2007.11.023", "ArticleIdList": ["10.3969/j.issn.0257-358X.2007.11.023"]}]}], "History": [{"Year": "2019", "Month": "3", "Day": "12"}, {"Year": "2019", "Month": "5", "Day": "31"}, {"Year": "2019", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "6", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["31293425", "PMC6604035", "10.3389/fphar.2019.00706"]}}]}